SpaceX, humanoids and the new frontier capital stack

SpaceX is arranging a secondary sale of insider shares at a price that implies up to an $800B valuation.

The transaction would move SpaceX ahead of OpenAI as the highest-valued private tech company globally.

Management has signalled a potential IPO for the whole company – including Starlink – in 2026, based on media reporting (not yet formal filings).

Confirms space as a peer to AI in perceived value: investors are willing to price orbital infrastructure like hyperscale software.

Sets a new benchmark for secondary liquidity in late-stage deep-tech, influencing pricing for other SpaceX-adjacent private names.

Highlights the gap between private vs public space valuations, with public comps trading far below this implied multiple.

For LPs and family offices already exposed via funds, this reprices existing holdings and may pull forward exit or secondary opportunities.

Those without direct SpaceX access are still limited to listed “picks and shovels” plays in launch, components, in-space logistics and data.

Dispersion of quality is high: the headline valuation hides a long tail of space companies with weaker economics and limited access to defence budgets.

Generative Bionics, a spinoff from the Italian Institute of Technology, closed a funding round of about €70m.

Capital will support product development and scaling manufacturing of industrial-grade humanoid robots for factories and logistics, targeting deployments by 2026.

Investors include both strategic industrial players and Tether, extending the pattern of crypto-adjacent capital moving into physical AI and robotics.

Confirms that the humanoid robotics race is now European as well, not only US–China.

Signals growing comfort that humanoid platforms are moving from demo to pilots in industrial settings on a 1–3 year horizon.

The cross-sector investor mix (energy, industrials, semis, crypto) hints at partnership-driven go-to-market, not just VC-only funding.

Humanoid robotics ties into structural themes of ageing populations and labour automation, particularly in services and light industry.

In parallel, Tether’s talks to lead a ~€1bn round in Neura Robotics underline that very large cheques are now entering European humanoids.

Execution risk is significant: unit economics, safety certification and labour/regulatory pushback remain unresolved; valuations embed option-like growth assumptions.

Germany’s space defence strategy formally defines space as a defence-relevant domain with priorities in resilience, surveillance and secure communications.

The strategy notes that public budgets alone are insufficient and explicitly references the role of private investors and commercial operators.

The move aligns Germany with NATO’s push to integrate commercial space providers into defence planning and operations.

Creates a clearer demand anchor for European space startups in ISR, secure comms and space-domain awareness.

Suggests more predictable revenue visibility, where commercial operators can sell into defence frameworks rather than speculative commercial LEO constellations.

Signals that European governments are willing to lean on commercial players, not just legacy primes, to deliver critical capabilities.

Policy clarity reduces risk: the question “will governments actually buy?” becomes less binary for European space portfolios.

May accelerate consolidation and roll-ups in segments such as optical/radar imaging, in-orbit servicing and secure PNT (positioning, navigation, timing).

Reinforces space as a defence-adjacent growth sector, not a pure exploration bet, which matters for mandate-constrained capital.

Researchers unveiled a new brain-computer interface (BCI) chip using advanced silicon fabrication to minimise thickness and power.

The system creates a wireless link between neural activity and external AI models, potentially enabling real-time interpretation of movement or speech intent.

Work remains at preclinical stage; long-term safety, durability and efficacy in chronic human implants still need to be proven.

Supports the thesis that BCI is moving from bulky, wired rigs to fully implanted systems with high bandwidth.

Introduces competition for headline players like Neuralink and Synchron from academic–industry partnerships.

Raises ethical and regulatory questions around data privacy, cognitive enhancement and medical device oversight.

Most investable exposure is indirect: med-tech, semiconductor and AI companies supplying components or algorithms.

Regulatory pathways (FDA/EMA) will largely determine commercialisation speed; these will be medical implants first, not consumer gadgets.

Given long timelines and binary trial risk, BCI fits as a moonshot R&D allocation, not a near-term cash-flow story.

The EU’s IF25 call under the Innovation Fund opened in early December, extending a programme with an estimated €40bn budget (2020–2030) for innovative low-carbon technologies.

Battery Innovation Days 2025 brought together industry, policymakers and researchers in Graz to discuss next-generation storage and supply-chain resilience.

The ITER fusion project is entering a critical assembly/testing phase, with the goal of demonstrating Q=10 (tenfold energy output vs input).

Innovation Fund grants and auctions are becoming de facto price signals for early-stage climate tech (CCUS, hydrogen, industrial decarbonisation).

Battery forums show that “beyond-lithium” concepts (solid state, flow, sodium, etc.) are now about scale-up economics, not just lab chemistry.

ITER and other fusion efforts highlight the dual reality of enormous potential upside vs non-trivial timelines and engineering risk.

The Innovation Fund is non-dilutive capital: winners can extend runway and de-risk project finance, but competition and compliance are heavy.

For LPs, these public-sector signals help map which parts of the climate stack may enjoy policy tailwinds over the next decade.

Fusion and advanced batteries remain long-dated, binary R&D bets, where political and regulatory support are nearly as important as scientific progress